Core Viewpoint - Dize Pharmaceutical has seen a 5.19% increase in stock price, reaching 64.86 CNY per share, with a total market capitalization of 29.913 billion CNY as of November 13 [1] Company Overview - Dize Pharmaceutical (Jiangsu) Co., Ltd. was established on October 27, 2017, and went public on December 10, 2021. The company is located in Wuxi, Jiangsu Province, and focuses on the research and industrialization of innovative drugs, with 100% of its main business revenue derived from drug sales [1] Fund Holdings - Jin Yuan Shun An Fund has a significant holding in Dize Pharmaceutical, with its Jin Yuan Shun An Medical Health Mixed A Fund (007861) maintaining 35,200 shares, unchanged from the previous period, representing 4.26% of the fund's net value, ranking as the seventh largest holding [2] - The Jin Yuan Shun An Medical Health Mixed A Fund was established on July 29, 2021, with a current scale of 38.3683 million CNY. Year-to-date returns are 11.56%, with a one-year return of 0.37%, and a cumulative loss of 54.15% since inception [2] Fund Manager Performance - The fund managers of Jin Yuan Shun An Medical Health Mixed A Fund are Chen Mingjie and Zhang Haidong. Chen has been in position for 2 years and 19 days, managing assets totaling 72.6952 million CNY, with the best return of 5.16% and the worst return of -26.14% during his tenure [3] - Zhang has been in position for 81 days, managing assets of 628 million CNY, with the best return of 1.4% and the worst return of -3.77% during his short tenure [3]